,
your personalized virtual assistant to find clinical trials. Go head, 
Judy Sisk
Consultants in Blood Disorders and ...Louisville, Kentucky - 40207 (502-897-1166) |
- CLINICAL TRIALS 10
- CONDITIONS11
- INTERVENTIONS19
- SINCE2005
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
August 2008 - August 2011
A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
January 2009 - January 2016
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
December 2009 - December 2016
Carboplatin Docetaxel Bevacizumab and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
December 2007 - December 2010
High-dose Bevacizumab in Advanced Renal Carcinoma Patients
February 2007 - July 2011
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
January 2007 - June 2011
A Trial of Carboplatin Pemetrexed and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type Non-Small-Cell Lung Cancer
June 2010 - June 2012
Preoperative Pemetrexed and Carboplatin for Select Stage IB II and III Non-Squamous Non-Small-Cell Lung Cancer
June 2009 - December 2014
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
August 2008 - July 2011
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
September 2005 - July 2009
Breast Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Neoplasms, Unknown Primary
Carcinoma, Small Cell
Lymphoma, Follicular
Rituximab
Paclitaxel
Carboplatin
Bevacizumab
Erlotinib
Other Treatment As Determined By Physician
Cyclophosphamide
Rad001
Pegfilgrastim
Sorafenib
Pazopanib
Doxorubicin
Pemetrexed
Ixabepilone (Ixempra)
Paclitaxel (Taxol)
Amrubicin
Docetaxel, Carboplatin, Bevacizumab, Erlotinib
Docetaxel, Carboplatin
Panitumumab
